Evaluation of Acclimate Feature for Positive Airway Pressure (PAP) Therapy

Obstructive Sleep Apnea Clinical Trial

Official title: Evaluation of Positive Airway Pressure (PAP) Feature to Improve Patient Adherence to Therapy

Status Completed

Clinical Trial Summary

The purpose of the study is to evaluate if using the Acclimate feature at the beginning of Positive Airway Pressure (PAP) therapy results in patients using their PAP therapy at least as long as they would standard therapy. Additionally, the Acclimate feature will be evaluated with regard to patient comfort, ease of acceptance of PAP therapy, leak events, and respiratory events.

Clinical Trial Description

Acclimate has been designed as a comfort feature for patients starting PAP therapy. The feature allows acclimatization to the targeted positive airway pressure setting. Using the Acclimate feature, the pressure increases incrementally over a period of time. The feature can be only be used for a set period of time, afterwards which the device initiates the therapeutic session at the prescribed pressure. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Obstructive Sleep Apnea
• Sleep Apnea, Obstructive

• NCT number: NCT01421654
• Study type: Interventional
• Source: ResMed
• Status: Completed
• Phase: N/A
• Start date: September 2011
• Completion date: December 2011